Acanthosis Nigricans During Treatment With Aripiprazole

Publication Date

2014

Journal Title

Am J Ther

Abstract

Aripiprazole is typically regarded as a metabolically sparing agent, in contrast to other second-generation antipsychotics, which are widely known to lead to weight gain and increase the cardiometabolic risk. We report for the first time the emergence of Acanthosis nigricans, a dermatological correlate of insulin resistance, during treatment with aripiprazole in an adolescent with a family history of diabetes mellitus.

Volume Number

21

Issue Number

3

Pages

E90-E93

Document Type

Article

EPub Date

2012/09/27

Status

Faculty, Northwell Researcher

Facility

School of Medicine; Northwell Health

Primary Department

General Internal Medicine

Additional Departments

Psychiatry; Molecular Medicine

PMID

23011171

DOI

10.1097/MJT.0b013e3182491e29

For the public and Northwell Health campuses

Share

COinS